ARSUF (Fagron) FFO


ARSUF Fagron SA ARSUF
92 GF Score
Price $26.53
GF Value $26.46
! 6 Warning Signs
View Full Analysis

What is Fagron FFO?

FFO (Funds from operations) only applies to REITs.

ARSUF
92GF Score
Fagron SA ARSUF
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fagron (ARSUF) Overvalued in 2026?

Based on GuruFocus' analysis, Fagron stock appears to be overvalued. The current stock price of $26.53 is trading 0.3% above its estimated GF Value™ of $26.46.

Key valuation signals for ARSUF:

  • FFO:
  • GF Value™: $26.46 vs. price of $26.53 (0.3% above fair value)
  • GF Score™: 92/100 with 6 warning signs

No single metric tells the full story. See the ARSUF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fagron Business Description

Address Fascinatio Boulevard 350, Rotterdam, ZH, NLD, 3065 WB
Fagron SA is a Belgium-based multinational pharmaceutical compounding company specializing in pharmaceutical compounding. It operates across the pharmaceutical compounding value chain, developing and manufacturing personalized medicines in collaboration with pharmacists, prescribers, hospitals, and other healthcare providers. The company has three segments: Essentials, Brands, and Compounding Services. The majority of the revenue is derived from the Essentials segment, which provides raw materials, equipment, packaging, and supplies for compounding to pharmacies and healthcare industries across EMEA, Latin America, and North America - Pacific. Geographically, it generates the maximum revenue from Fagron North America - Pacific.
92GF Score

Get the complete analysis for ARSUF

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.53
Price
$26.46
GF Value